Opinión De Un Grupo De Expertos Sobre Facilitadores Para La Implantación Del Seguimiento Farmacoterapéutico En Las Farmacias Comunitarias Españolas - Opinion of a group of experts on facilitators for introducing pharmacotherapy follow up in Spanish communities
- Sociedad Española de Farmacia Comunitaria
- Publication Type:
- Journal Article
- Farmacéuticos Comunitarios, 2013, 5 (3), pp. 96 - 102
- Issue Date:
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
A focus group, consisting of members of the Community Pharmacy Pharmaceutical Care Forum, was created as part of a research study into prioritising facilitators for introducing pharmaceutical follow-up in Spanish community pharmacies The aim was to explore their options regarding the facilitators prioritised in this study that had been defined as “Incentives”, “External Campaigns”, “Expertise in Pharmacotherapy Follow-Up Service” and “Pharmacist Professionalism”. The priority facilitator of the study, “Incentives”, mainly includes economic incentives, which are essential for the introduction and sustainability of pharmacotherapy follow-up services, although they also refer to other kinds of incentive, such as professional recognition. The participants agreed with the results of the study, which indicate the need for a preliminary payment to introduce new professional services. It is considered that this payment is justified by the benefits that the pharmacotherapy follow-up service offers patients’ health and the reduction in health expenses derived from the correct use of medication. Therefore, various methods of economic incentives for pharmacists who offer pharmacotherapy follow-up services were proposed. As far as professional recognition is concerned, the accreditation of the pharmacy that offers pharmacotherapy follow-up services was considered to be an incentive, and that this service should be relevant at a curricular level. Carrying out external campaigns as well as the existence of a professional pharmaceutical expert, qualified and accredited to offer the new professional pharmaceutical services (PPS) were also confirmed as being very important.
Please use this identifier to cite or link to this item: